Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity

Author(s):  
Jia-yi He ◽  
Quan Hong ◽  
Bi-xia Chen ◽  
Shao-yuan Cui ◽  
Ran Liu ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-11 ◽  
Author(s):  
Barbara Lewko ◽  
Elżbieta Latawiec ◽  
Anna Maryn ◽  
Anna Barczyńska ◽  
Michał Pikuła ◽  
...  

Podocyte injury is associated with progression of many renal diseases, including diabetic nephropathy. In this study we examined whether aldose reductase (AR), the enzyme implicated in diabetic complications in different tissues, is modulated by high glucose and osmolarity in podocyte cells. AR mRNA, protein expression, and activity were measured in mouse podocytes cultured in both normal and high glucose and osmolarity for 6 hours to 5 days. Hyperosmolarity acutely stimulated AR expression and activity, with subsequent increase of AR expression but decrease of activity. High glucose also elevated AR protein level; however, this was not accompanied by respective enzyme activation. Furthermore, high glucose appeared to counteract the osmolarity-dependent activation of AR. In conclusion, in podocytes AR is modulated by high glucose and increased osmolarity in a different manner. Posttranslational events may affect AR activity independent of enzyme protein amount. Activation of AR in podocytes may be implicated in diabetic podocytopathy.


1989 ◽  
Vol 21 (4) ◽  
pp. 285-291 ◽  
Author(s):  
Otto Hockwin ◽  
Peter Müller ◽  
Jan Krolczyk ◽  
Bette A. McCue ◽  
Philip R. Mayer

Molekul ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. 88
Author(s):  
Ruswanto Ruswanto ◽  
Richa Mardianingrum ◽  
Siswandono Siswandono ◽  
Dini Kesuma

Aldose reductase is an enzyme that catalyzes one of the steps in the sorbitol (polyol) pathway that is responsible for fructose formation from glucose. In diabetes, aldose reductase activity increases as the glucose concentration increases. The purpose of this research was to identify and develop the use of artemisinin as an anti-diabetic candidate through in silico studies, including reverse docking, receptor analysis, molecular docking, drug scan, absorption, and distributions and toxicity prediction of artemisinin. Based on the results, we conclude that artemisinin can be used as an anti-diabetic candidate through inhibition of aldose reductase


2019 ◽  
Vol 59 ◽  
pp. 13-23 ◽  
Author(s):  
Yipeng Liu ◽  
Hong Su ◽  
Chaoqun Ma ◽  
Dong Ji ◽  
Xiaoli Zheng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document